https://www.rttnews.com/3419638/new-zealand-posts-nz-323-million-trade-deficit.aspx?type=alleco
Jan 28, 2024 - New Zealand had a merchandise trade deficit of NZ$323 million in December, Statistics New Zealand said on Monday.
0
rttnews:3421796913559640588
0
https://www.cnbc.com/2024/01/31/gsk-posts-blowout-rsv-vaccine-sales-raises-outlook.html
Jan 31, 2024 - The RSV shot, called Arexvy, booked £1.2 billion, or $1.5 billion, in sales after only being on the market for roughly half a year.
0
cnbc:632480491798826131
0
https://www.cnbc.com/2024/02/02/bristol-myers-squibb-bmy-q4-earnings-report-2023.html
Feb 02, 2024 - Bristol Myers Squibb also issued its full-year 2024 forecast, which was generally in line with expectations.
0
cnbc:5865826120474640758
0
https://seekingalpha.com/news/4062948-earnings-preview-gilead-set-to-roll-out-q4-results-post-market-tuesday?source=feed_sector_healthcare
Feb 05, 2024 - Gilead Sciences (GILD) is expected to report a higher Q4 2023 profit on lower revenue after market close on Tuesday. Read more here.
0
sa:-3009156126378729989
0
https://seekingalpha.com/news/4064686-aim-stock-dips-amid-mixed-results-for-post-covid-fatigue-therapy?source=feed_sector_healthcare
Feb 08, 2024 - AIM ImmunoTechn (AIM) stock dipped after the company reported mixed topline results from a Phase 2 study of Ampligen for post-COVID fatigue. Read more here.
0
sa:6343911402384242741
0
https://seekingalpha.com/news/4068521-medtronic-q3-in-focus-amid-medtechs-gains?source=feed_sector_healthcare
Feb 18, 2024 - Medtronic is set to report its Q3 FY24 results, with high expectations following strong performances from its peers in the MedTech sector. Read more here.
0
sa:5198030424215883179
0
https://www.cnbc.com/2024/02/21/hsbc-pre-tax-annual-profit-jumps-78percent-misses-market-estimates.html
Feb 21, 2024 - The London-based lender suffered a "valuation adjustment" of $3 billion on its stake in Bank of Communications.
0
cnbc:-1953986768527442588
0
https://seekingalpha.com/news/4069812-moderna-to-preview-post-covid-prospects-q4?source=feed_sector_healthcare
Feb 21, 2024 - Moderna (MRNA) is set to release its Q4 2023 results, with investors focused on how the vaccine maker will address its post-COVID growth concerns. Read more here.
0
sa:8628822366856153788
0
https://www.cnbc.com/2024/03/06/foot-locker-fl-earnings-q4-2023.html
Mar 06, 2024 - Foot Locker reported earnings as CEO Mary Dillon leads the legacy retailer through an ambitious turnaround. But some analysts say it has gone too slowly.
0
cnbc:2242893084978685559
0
https://www.rttnews.com/story.aspx?Id=3429895
Mar 05, 2024 - Shares of CASI Pharmaceuticals, Inc. (CASI) were gaining more than 49 percent in pre-market activity on Nasdaq after the biopharmaceutical company announced Tuesday positive interim Phase 1 Data for BI-1206 (Anti-FcyRIIB antibody) in patients with relapsed/refractory or R/R indolent Non-Hodgkin's Lymphoma or iNHL.
0
rttnews:7072203401059335956
0